Clinical Trial Update: Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Arnica tincture for cutaneous leishmaniasis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Arnica tincture (arnica tincture)

Snippet

Sponsor: Universidad de Antioquia | Conditions: Leishmaniasis, Cutaneous | Phase 3 | Status: RECRUITING